Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples